Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma

Robert K. Zeldin, Pascal Demoly, Philippe Betting, Patricia Rodriguez, Angélique Racaud, Martine Le Gall
European Respiratory Journal 2013 42: P3157; DOI:
Robert K. Zeldin
1Global Clinical Development, Stallergenes S.A., Antony, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Demoly
2Pneumology and Addictology, Montpellier University Hospital, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Betting
3Clinical Studies, SGS, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Rodriguez
1Global Clinical Development, Stallergenes S.A., Antony, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angélique Racaud
1Global Clinical Development, Stallergenes S.A., Antony, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martine Le Gall
1Global Clinical Development, Stallergenes S.A., Antony, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Efficacy and safety of sublingual immunotherapy tablets (SLIT) of house dust mite (HDM) allergen extracts have been demonstrated in patients with HDM allergic rhinitis.

Aims and objectives: Here we report their safety and tolerability in patients with HDM-associated allergic asthma.

Methods: Adults with a history of HDM allergic asthma (≥ 1 year) controlled with therapies consistent with GINA treatment step 2, 3 or 4, a positive skin prick test to HDM, and HDM-specific serum IgE ≥ 0.7 kU/L were eligible for this DBPC study. Participants, stratified according to GINA treatment step at screening, were randomised 3:1 within dose-regimen groups to receive either increasing doses of SLIT tablets of HDM allergen extracts or placebo for 10 consecutive days. Four dose regimens with progressive incremental dosing from 300IR to 1000IR (IR=Index of Reactivity) were studied sequentially. Adverse events (AEs), physical examination, vital signs, spirometry, ECG and laboratory tests were analysed descriptively.

Results: 63 patients received either 300IR (n=11), 500IR (n=12), 800IR (n=12), 1000IR (n=12) or Placebo (n=16). No deaths, serious AEs, anaphylaxis, epinephrine use, or treatment-related asthma exacerbation were reported. The most common AEs were mild oropharyngeal reactions which resolved without treatment. A similar safety profile was observed in patients regardless of asthma treatment step at screening or the dose administered.

Conclusion: Sublingual tablets of HDM allergen extracts administered with ascending doses up to 1000IR were well tolerated in patients with HDM-associated allergic asthma and are suitable for further clinical evaluation.

  • Allergy
  • Immunology
  • Treatments
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma
Robert K. Zeldin, Pascal Demoly, Philippe Betting, Patricia Rodriguez, Angélique Racaud, Martine Le Gall
European Respiratory Journal Sep 2013, 42 (Suppl 57) P3157;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma
Robert K. Zeldin, Pascal Demoly, Philippe Betting, Patricia Rodriguez, Angélique Racaud, Martine Le Gall
European Respiratory Journal Sep 2013, 42 (Suppl 57) P3157;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Effect of FESS on asthma patients with nasal polyposis and chronic sinusitis
  • Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
  • Knowledge of asthma is associated with inhalation technique in elderly patients with asthma
Show more 5.3 Allergy and Immunology

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society